Radioembolization with 90 Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

ConclusionRadioembolization after systemic radionuclide treatments is safe, and the occurrence of radioembolization-induced liver disease is rare.Level of Evidence4, case series.

Source: CardioVascular and Interventional Radiology - January 16, 2020 Category: Radiology Source Type: research